Biotechnology exchange traded funds (ETFs) are on the move this morning. Here are some stories on the subject that may interest you:
- Health Care Reform and Biotech ETFs: Will There Be Opportunities?
- Why Biotech ETFs May Be the Better Choice
- Can Obama’s Push Reignite Biotech and Health Care ETFs?
- How Biotech ETFs Can Rise Above Challenges
- Comparing the ETFs of the Health Care Sector
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.